{"id":114774,"date":"2021-05-24T10:00:00","date_gmt":"2021-05-24T10:00:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2873753"},"modified":"2021-05-24T10:00:00","modified_gmt":"2021-05-24T10:00:00","slug":"onychomycosis-market-research-report-2030-industry-analysis-drugs-epidemiology-and-key-companies-by-delveinsight-moberg-pharma-blueberry-therapeutics-mycovia-pharmaceuticals-bausch-health-pfi","status":"publish","type":"post","link":"http:\/\/ipsnews.net\/business\/2021\/05\/24\/onychomycosis-market-research-report-2030-industry-analysis-drugs-epidemiology-and-key-companies-by-delveinsight-moberg-pharma-blueberry-therapeutics-mycovia-pharmaceuticals-bausch-health-pfi\/","title":{"rendered":"Onychomycosis Market Research Report 2030: Industry Analysis, Drugs, Epidemiology and Key Companies by DelveInsight | Moberg Pharma, Blueberry Therapeutics, Mycovia Pharmaceuticals, Bausch Health, Pfizer and Others"},"content":{"rendered":"<p><img decoding=\"async\" width=\"200\" height=\"50\" src=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-DelveInsight20Logo2028229.jpg\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"\" loading=\"lazy\" style=\"display: block; margin-bottom: 5px; clear:both;max-width: 100%;\" link_thumbnail=\"\" \/><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><a href=\"https:\/\/www.delveinsight.com\/report-store\/onychomycosis-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Onychomycosis Market Insights Report<\/strong><\/a><span style=\"font-weight: 400;\"> offers a detailed analysis of Disease, its causes, symptoms, diagnostics modalities, and treatment options.&nbsp;<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The report also offers comprehensive insights into <\/span><strong>Onychomycosis market size<\/strong><span style=\"font-weight: 400;\">, epidemiology, emerging therapies, market drivers, market barriers, ongoing Onychomycosis clinical trials, collaboration in the space, and key pharmaceutical companies actively pushing the growth of Onychomycosis market size forward<\/span><span style=\"font-weight: 400;\"> in the 7MM [US, EU5(Germany, France, the United Kingdom, Spain, and Italy) and Japan].<\/span><\/p>\n<p><strong>Some of the key highlights from the <\/strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/onychomycosis-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Onychomycosis Market<\/strong><\/a><strong> Insights:&nbsp;<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">As per Delveinsight, Onychomycosis Market was estimated to be <\/span><strong>USD 3842.6 million in 2017<\/strong><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">In 2017, Onychomycosis&#8217;s prevalent population in the <\/span><strong>United States<\/strong><span style=\"font-weight: 400;\"> was found to be <\/span><strong>35,829,110<\/strong><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>Spain<\/strong><span style=\"font-weight: 400;\"> reported the <\/span><strong>least<\/strong><span style=\"font-weight: 400;\"> number of prevalent cases in the 7MM.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">As per Delveinsight&#8217;s estimates, the total prevalent cases for Onychomycosis were highest in the <\/span><strong>United States<\/strong><span style=\"font-weight: 400;\">, followed by Japan &amp; France.<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>MOB-015<\/strong><span style=\"font-weight: 400;\"> (Moberg Pharma), which is expected to launch during the forecast period (2020&ndash;2030), is anticipated to be the most promising therapy amongst all the other desired drug candidates.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">According to DelveInsight&#8217;s analysis, <\/span><strong>no gender bias<\/strong><span style=\"font-weight: 400;\"> was observed in the case of Onychomycosis.<\/span><\/li>\n<\/ul>\n<p><strong>Onychomycosis Disease Overview:<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">Onychomycosis, the most common fungal nail infection that has been evaluated to account for about half of all nail diseases. It causes discoloration and thickening of the affected nail. Onychomycosis was initially believed to be caused predominantly by dermatophytes; however, new studies have unveiled that mixed infections &amp; those caused by nondermatophyte molds are more prevalent than previously thought, especially in warmer climates.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Although not life-threatening, fungal nail infections are significant public health concerns due to their high prevalence, inadequate response to therapy &amp; significant clinical, social and financial impact.<\/span><\/p>\n<p><span style=\"font-weight: 400;\"><img decoding=\"async\" src=\"http:\/\/beta-kiosk.icrowdnewswire.com\/assets\/source\/users\/delveinsight\/Onychomycosis%20Market.jpg?1621835418796\" alt=\"Onychomycosis Market\" \/><\/span><\/p>\n<p><strong>Onychomycosis Symptoms:<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">Symptoms include <\/span><strong>yellow or white nail discoloration, separation of the nail from the nail bed, thickening of the nail,<\/strong><strong> Dry o<\/strong><strong>r scaly skin around the nail, <\/strong><strong>Foul s<\/strong><strong>mell,<\/strong><span style=\"font-weight: 400;\"> Etc.<\/span><\/p>\n<p><strong>For more insights into Disease, treatment, and causes, reach out to <\/strong><a href=\"https:\/\/www.delveinsight.com\/sample-request\/onychomycosis-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Onychomycosis Treatment Landscape<\/strong><\/a><strong>.<\/strong><\/p>\n<p><strong>Onychomycosis Epidemiology Segmentation&nbsp;<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">The <\/span><a href=\"https:\/\/www.delveinsight.com\/report-store\/onychomycosis-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><span style=\"font-weight: 400;\">Onychomycosis Market<\/span><\/a><span style=\"font-weight: 400;\"> report proffers epidemiological analysis for the study period 2017-30 in the 7MM segmented into:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Onychomycosis Prevalence&nbsp;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Severity Specific Onychomycosis Prevalence&nbsp;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Diagnosed and Treatable Cases of Onychomycosis<\/span><\/li>\n<\/ul>\n<p><strong>Visit for more @ <\/strong><a href=\"https:\/\/www.delveinsight.com\/sample-request\/onychomycosis-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Onychomycosis Epidemiological Insights<\/strong><\/a><strong>.<\/strong><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/onychomycosis-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Onychomycosis Pipeline<\/strong><\/a><strong> Therapies and Key Companies&nbsp;<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Moberg Pharma: MOB-015<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Blueberry Therapeutics: BB2603<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Mycovia Pharmaceuticals: VT-1161<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Bausch Health: Jublia\/\/Clenafin (efinaconazole)<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Pfizer: Kerydin (tavaborole)<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Sato Pharmaceutical\/Bausch Health: Luliconazole<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Sato Pharmaceutical\/ Eisai: Nialin<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Meiji Seika Pharma: ME111&nbsp;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">NovaBiotics: NP213 (Novexatin)<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Halllux: HTS-519<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">And Many Others<\/span><\/li>\n<\/ul>\n<p><strong>For more information, visit <\/strong><a href=\"https:\/\/www.delveinsight.com\/sample-request\/onychomycosis-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Onychomycosis Market Analysis, Patient Pool, and Emerging Therapies<\/strong><\/a><strong>.<\/strong><\/p>\n<p><strong>Scope of the Report<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">11 Years Forecast<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">7MM Coverage&nbsp;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Descriptive overview of Onychomycosis, covering causes, signs and symptoms, pathophysiology, diagnosis, and currently available therapies<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Comprehensive insight into Onychomycosis epidemiology and treatment in the 7MM<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Current and emerging therapies for Onychomycosis<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Onychomycosis market drivers and barriers&nbsp;<\/span><\/li>\n<\/ul>\n<p><strong>Get in touch with our Business executive @ <\/strong><a href=\"https:\/\/www.delveinsight.com\/sample-request\/onychomycosis-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Onychomycosis Market Landscape Analysis<\/strong><\/a><strong>.<\/strong><\/p>\n<p><strong>Table of Contents&nbsp;<\/strong><\/p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">1<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Key Insights<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">2<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Report Introduction<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">3<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Competitive Intelligence Analysis for Onychomycosis<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">4<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Onychomycosis Market Overview at a Glance<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">5<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Executive Summary of Onychomycosis<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">6<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Onychomycosis Epidemiology and Market Methodology<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">7<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Onychomycosis Epidemiology and Patient Population<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">8<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Onychomycosis Patient Journey<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">9<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Treatment Algorithm, Current Treatment, and Medical Practices<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">10<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Key Endpoints in Onychomycosis Clinical Trials<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">11<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Onychomycosis Marketed Therapies&nbsp;<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">12<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Onychomycosis Emerging Therapies<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">13<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Onychomycosis: 7 Major Market Analysis<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">14<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Attribute analysis<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">15<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Access and Reimbursement Overview of Onychomycosis<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">16<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">KOL Reviews<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">17<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Case Reports<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">18<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Onychomycosis Market Drivers<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">19<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Onychomycosis Market Barriers<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">20<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">SWOT Analysis<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">21<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Disclaimer<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">21<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">DelveInsight Capabilities<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">22<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">About DelveInsight<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span style=\"font-weight: 400;\">&nbsp;<\/span><\/p>\n<p><strong>Learn more about the report offerings @ <\/strong><a href=\"https:\/\/www.delveinsight.com\/sample-request\/onychomycosis-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Onychomycosis Market Outlook<\/strong><\/a><\/p>\n<p><strong>Latest Blogs:<\/strong><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/blog\/medtech-news-and-updates\/\"><strong>MedTech Industry: Commercial, Regulatory and Clinical Updates<\/strong><\/a><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/blog\/hereditary-deafness-market\/\"><strong>Who is Going to be a Trendsetter in the Hereditary Deafness Market?<\/strong><\/a><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/blog\/substance-use-disorder-sud-treatment-market\/\"><strong>The Rising Burden of Substance Use Disorder And The Treatment Scenario<\/strong><\/a><\/p>\n<p><strong>Related Blog:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/blog\/onychomycosis-therapeutics-market-impact-of-new-topical-anti-fungal-drugs\/\"><strong>Onychomycosis therapeutics market: Impact of new topical anti-fungal drugs<\/strong><\/a><\/p>\n<p><strong>Related Reports<\/strong><span style=\"font-weight: 400;\">:<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/adeno-associated-virus-vectors-in-gene-therapy-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Adeno-Associated Virus Vectors in Gene Therapy Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>Adeno-Associated Virus Vectors in Gene Therapy Market Insight, Epidemiology and Market Forecast &#8211; 2030&#8242;<\/strong><span style=\"font-weight: 400;\"> report will provide Adeno-Associated Virus Vectors in Gene Therapy Market, Epidemiological &amp; Therapeutics market<\/span> <span style=\"font-weight: 400;\">domain with a special focus on key companies such as <\/span><strong>Advernum Biotechnologies, Lysogene, uniQure, Spark Therapeutics, MeiraGTx, Rocket Pharmaceuticals, and several others.<\/strong><span style=\"font-weight: 400;\">&nbsp;<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/acute-bacterial-skin-and-skin-structure-infections-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>ABSSSI Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s &#8220;ABSSSI Market Insights, Epidemiology, and Market Forecast-2030&#8221; report will provide Acute Bacterial Skin and Skin Structure Infections Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as <\/span><strong>Basilea Pharmaceutica, Motif Bio, Innovation Pharmaceuticals,<\/strong> <strong>Debiopharm, MicuRx Pharmaceuticals, Destiny Pharma,<\/strong> <strong>KBP Biosciences and several others.<\/strong><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/aspergillosis-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Aspergillosis Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s &#8216;Aspergillosis Market Insights, Epidemiology and Market Forecast &ndash; 2030&#8217; report will provide Aspergillosis Market, Epidemiological &amp; Therapeutics market domain with special focus on key companies such as <\/span><strong>F2G, Zambon SpA, TFF Pharmaceuticals, Scynexis, Pulmocide, Pulmatrix, and several others.<\/strong><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/community-acquired-bacterial-pneumonia-cabp-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Community-Acquired Bacterial Pneumonia Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s &#8216;Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology and Market Forecast &ndash; 2030&#8217; report will provide Community-Acquired Bacterial Pneumonia Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as <\/span><strong>Combioxin, BioAegis Therapeutics, Biotest, Tigenix, and several others.<\/strong><\/p>\n<p><strong>Other Reports:&nbsp;<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/report-store\/electrophysiology-devices-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Electrophysiology Devices Market<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/report-store\/growth-hormone-deficiency-ghd-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Growth Hormone Deficiency Market<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/report-store\/interventional-neuroradiology-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Interventional Neuroradiology Market<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/report-store\/intracranial-pressure-monitoring-devices-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Intracranial Pressure Monitoring Devices Market<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/report-store\/foot-and-ankle-devices-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Foot and Ankle Devices Market<\/strong><\/a><\/li>\n<\/ul>\n<p><strong>About DelveInsight&nbsp;<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight is a leading Market Research &amp; Business Consultant focused purely on life sciences. It helps pharma companies by providing them with end-to-end services to boost their performance.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Get access to all the Pharma &amp; healthcare market research reports through our market research subscription-based platform <\/span><a href=\"https:\/\/www.pharmdelve.com\/?utm_source=gnw&amp;utm_medium=pr&amp;utm_campaign=vpr\"><strong>PharmDelve<\/strong><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">&nbsp;<\/span><strong>Connect With Us at:<\/strong><\/p>\n<p class=\"tags\">Tags: <a href=\"https:\/\/icrowdnewswire.com\/tag\/onychomycosistreatment\/\" rel=\"tag\">Onychomycosistreatment<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/onychomycosiscauses\/\" rel=\"tag\">Onychomycosiscauses<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/onychomycosissymptoms\/\" rel=\"tag\">Onychomycosissymptoms<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/onychomycosismarket\/\" rel=\"tag\">Onychomycosismarket<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/onychomycosis\/\" rel=\"tag\">Onychomycosis<\/a> <\/p>\n<div><strong>See Campaign: <\/strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/onychomycosis-market\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.delveinsight.com\/report-store\/onychomycosis-market<\/a><br \/><b>Contact Information:<\/b><br \/>Ankit Nigam info@delveinsight.com +91-9650213330 <\/p>\n<p><strong>&nbsp;<\/strong><a href=\"https:\/\/www.linkedin.com\/company\/delveinsight-business-research-llp\/\"><strong>LinkedIn<\/strong><\/a> <strong>|<\/strong><a href=\"https:\/\/www.facebook.com\/delveinsightindia\/\"> <strong>Facebook<\/strong><\/a> <strong>|<\/strong><a href=\"https:\/\/twitter.com\/delve_insight\"> <strong>Twitter<\/strong><\/a><\/p>\n<p><strong>Get Free Sample Copy of Report at: <\/strong><a href=\"https:\/\/www.delveinsight.com\/sample-request\/onychomycosis-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>https:\/\/www.delveinsight.com\/sample-request\/onychomycosis-market<\/strong><\/a><\/p>\n<p><b>Tags:<\/b><br \/><a href=\"\"><\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/menafn\/\" rel=\"category tag\">Menafn<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/reportedtimes\/\" rel=\"category tag\">Reportedtimes<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/ips\/\" rel=\"category tag\">IPS<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/extended-distribution\/\" rel=\"category tag\">Extended Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/research-newswire\/\" rel=\"category tag\">Research Newswire<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/language\/english\/\" rel=\"category tag\">English<\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"\" alt=\"image\" width=\"400\" height=\"300\" class=\"cwdfimg\" \/><\/div>\n<div>\n<h3>Contact Information:<\/h3>\n<p>Ankit Nigam<br \/> info@delveinsight.com<br \/> +91-9650213330 <\/p>\n<p><strong>\u00a0<\/strong><a href=\"https:\/\/www.linkedin.com\/company\/delveinsight-business-research-llp\/\"><strong>LinkedIn<\/strong><\/a> <strong>|<\/strong><a href=\"https:\/\/www.facebook.com\/delveinsightindia\/\"> <strong>Facebook<\/strong><\/a> <strong>|<\/strong><a href=\"https:\/\/twitter.com\/delve_insight\"> <strong>Twitter<\/strong><\/a><\/p>\n<\/p>\n<p><strong>Get Free Sample Copy of Report at: <\/strong><a href=\"https:\/\/www.delveinsight.com\/sample-request\/onychomycosis-market?utm_source=Icrowd&#038;utm_medium=pressrelease&#038;utm_campaign=apr\"><strong>https:\/\/www.delveinsight.com\/sample-request\/onychomycosis-market<\/strong><\/a><\/p>\n<\/p>\n<\/div>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/onychomycosis-market-research-report-2030-industry-analysis-drugs-epidemiology-and-key-companies-by-delveinsight-moberg-pharma-blueberry-therapeutics-mycovia-pharmaceuticals-bausch-health-pfi\/\">Onychomycosis Market Research Report 2030: Industry Analysis, Drugs, Epidemiology and Key Companies by DelveInsight | Moberg Pharma, Blueberry Therapeutics, Mycovia Pharmaceuticals, Bausch Health, Pfizer and Others<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\">Financial Market Brief<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight&rsquo;s Onychomycosis Market Insights Report offers a detailed analysis of Disease, its causes, symptoms, diagnostics modalities, and treatment options.&nbsp; The report also offers comprehensive insights into Onychomycosis market size, epidemiology, emerging therapies, market drivers, market barriers, ongoing Onychomycosis clinical trials, collaboration in the space, and key pharmaceutical companies actively pushing the growth of Onychomycosis market [&hellip;]<\/p>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/onychomycosis-market-research-report-2030-industry-analysis-drugs-epidemiology-and-key-companies-by-delveinsight-moberg-pharma-blueberry-therapeutics-mycovia-pharmaceuticals-bausch-health-pfi\/\">Onychomycosis Market Research Report 2030: Industry Analysis, Drugs, Epidemiology and Key Companies by DelveInsight | Moberg Pharma, Blueberry Therapeutics, Mycovia Pharmaceuticals, Bausch Health, Pfizer and Others<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/\">Financial Market Brief<\/a>.<\/p>\n<p> <a href=\"http:\/\/ipsnews.net\/business\/2021\/05\/24\/onychomycosis-market-research-report-2030-industry-analysis-drugs-epidemiology-and-key-companies-by-delveinsight-moberg-pharma-blueberry-therapeutics-mycovia-pharmaceuticals-bausch-health-pfi\/\" class=\"more-link\">Continue Reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":291,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-114774","post","type-post","status-publish","format-standard","hentry","category-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Onychomycosis Market Research Report 2030: Industry Analysis, Drugs, Epidemiology and Key Companies by DelveInsight | Moberg Pharma, Blueberry Therapeutics, Mycovia Pharmaceuticals, Bausch Health, Pfizer and Others - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ipsnews.net\/business\/2021\/05\/24\/onychomycosis-market-research-report-2030-industry-analysis-drugs-epidemiology-and-key-companies-by-delveinsight-moberg-pharma-blueberry-therapeutics-mycovia-pharmaceuticals-bausch-health-pfi\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Onychomycosis Market Research Report 2030: Industry Analysis, Drugs, Epidemiology and Key Companies by DelveInsight | Moberg Pharma, Blueberry Therapeutics, Mycovia Pharmaceuticals, Bausch Health, Pfizer and Others - Business\" \/>\n<meta property=\"og:description\" content=\"DelveInsight&rsquo;s Onychomycosis Market Insights Report offers a detailed analysis of Disease, its causes, symptoms, diagnostics modalities, and treatment options.&nbsp; The report also offers comprehensive insights into Onychomycosis market size, epidemiology, emerging therapies, market drivers, market barriers, ongoing Onychomycosis clinical trials, collaboration in the space, and key pharmaceutical companies actively pushing the growth of Onychomycosis market [&hellip;] The post Onychomycosis Market Research Report 2030: Industry Analysis, Drugs, Epidemiology and Key Companies by DelveInsight | Moberg Pharma, Blueberry Therapeutics, Mycovia Pharmaceuticals, Bausch Health, Pfizer and Others appeared first on Financial Market Brief. Continue Reading &rarr;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ipsnews.net\/business\/2021\/05\/24\/onychomycosis-market-research-report-2030-industry-analysis-drugs-epidemiology-and-key-companies-by-delveinsight-moberg-pharma-blueberry-therapeutics-mycovia-pharmaceuticals-bausch-health-pfi\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-24T10:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-DelveInsight20Logo2028229.jpg\" \/>\n<meta name=\"author\" content=\"iCrowdNewswire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"iCrowdNewswire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/05\/24\/onychomycosis-market-research-report-2030-industry-analysis-drugs-epidemiology-and-key-companies-by-delveinsight-moberg-pharma-blueberry-therapeutics-mycovia-pharmaceuticals-bausch-health-pfi\/\",\"url\":\"https:\/\/ipsnews.net\/business\/2021\/05\/24\/onychomycosis-market-research-report-2030-industry-analysis-drugs-epidemiology-and-key-companies-by-delveinsight-moberg-pharma-blueberry-therapeutics-mycovia-pharmaceuticals-bausch-health-pfi\/\",\"name\":\"Onychomycosis Market Research Report 2030: Industry Analysis, Drugs, Epidemiology and Key Companies by DelveInsight | Moberg Pharma, Blueberry Therapeutics, Mycovia Pharmaceuticals, Bausch Health, Pfizer and Others - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/05\/24\/onychomycosis-market-research-report-2030-industry-analysis-drugs-epidemiology-and-key-companies-by-delveinsight-moberg-pharma-blueberry-therapeutics-mycovia-pharmaceuticals-bausch-health-pfi\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/05\/24\/onychomycosis-market-research-report-2030-industry-analysis-drugs-epidemiology-and-key-companies-by-delveinsight-moberg-pharma-blueberry-therapeutics-mycovia-pharmaceuticals-bausch-health-pfi\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-DelveInsight20Logo2028229.jpg\",\"datePublished\":\"2021-05-24T10:00:00+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\"},\"breadcrumb\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/05\/24\/onychomycosis-market-research-report-2030-industry-analysis-drugs-epidemiology-and-key-companies-by-delveinsight-moberg-pharma-blueberry-therapeutics-mycovia-pharmaceuticals-bausch-health-pfi\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ipsnews.net\/business\/2021\/05\/24\/onychomycosis-market-research-report-2030-industry-analysis-drugs-epidemiology-and-key-companies-by-delveinsight-moberg-pharma-blueberry-therapeutics-mycovia-pharmaceuticals-bausch-health-pfi\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/05\/24\/onychomycosis-market-research-report-2030-industry-analysis-drugs-epidemiology-and-key-companies-by-delveinsight-moberg-pharma-blueberry-therapeutics-mycovia-pharmaceuticals-bausch-health-pfi\/#primaryimage\",\"url\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-DelveInsight20Logo2028229.jpg\",\"contentUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-DelveInsight20Logo2028229.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/05\/24\/onychomycosis-market-research-report-2030-industry-analysis-drugs-epidemiology-and-key-companies-by-delveinsight-moberg-pharma-blueberry-therapeutics-mycovia-pharmaceuticals-bausch-health-pfi\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Onychomycosis Market Research Report 2030: Industry Analysis, Drugs, Epidemiology and Key Companies by DelveInsight | Moberg Pharma, Blueberry Therapeutics, Mycovia Pharmaceuticals, Bausch Health, Pfizer and Others\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\",\"name\":\"iCrowdNewswire\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"caption\":\"iCrowdNewswire\"},\"sameAs\":[\"https:\/\/heymuse.com\/ips\"],\"url\":\"http:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Onychomycosis Market Research Report 2030: Industry Analysis, Drugs, Epidemiology and Key Companies by DelveInsight | Moberg Pharma, Blueberry Therapeutics, Mycovia Pharmaceuticals, Bausch Health, Pfizer and Others - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ipsnews.net\/business\/2021\/05\/24\/onychomycosis-market-research-report-2030-industry-analysis-drugs-epidemiology-and-key-companies-by-delveinsight-moberg-pharma-blueberry-therapeutics-mycovia-pharmaceuticals-bausch-health-pfi\/","og_locale":"en_US","og_type":"article","og_title":"Onychomycosis Market Research Report 2030: Industry Analysis, Drugs, Epidemiology and Key Companies by DelveInsight | Moberg Pharma, Blueberry Therapeutics, Mycovia Pharmaceuticals, Bausch Health, Pfizer and Others - Business","og_description":"DelveInsight&rsquo;s Onychomycosis Market Insights Report offers a detailed analysis of Disease, its causes, symptoms, diagnostics modalities, and treatment options.&nbsp; The report also offers comprehensive insights into Onychomycosis market size, epidemiology, emerging therapies, market drivers, market barriers, ongoing Onychomycosis clinical trials, collaboration in the space, and key pharmaceutical companies actively pushing the growth of Onychomycosis market [&hellip;] The post Onychomycosis Market Research Report 2030: Industry Analysis, Drugs, Epidemiology and Key Companies by DelveInsight | Moberg Pharma, Blueberry Therapeutics, Mycovia Pharmaceuticals, Bausch Health, Pfizer and Others appeared first on Financial Market Brief. Continue Reading &rarr;","og_url":"https:\/\/ipsnews.net\/business\/2021\/05\/24\/onychomycosis-market-research-report-2030-industry-analysis-drugs-epidemiology-and-key-companies-by-delveinsight-moberg-pharma-blueberry-therapeutics-mycovia-pharmaceuticals-bausch-health-pfi\/","og_site_name":"Business","article_published_time":"2021-05-24T10:00:00+00:00","og_image":[{"url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-DelveInsight20Logo2028229.jpg","type":"","width":"","height":""}],"author":"iCrowdNewswire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"iCrowdNewswire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ipsnews.net\/business\/2021\/05\/24\/onychomycosis-market-research-report-2030-industry-analysis-drugs-epidemiology-and-key-companies-by-delveinsight-moberg-pharma-blueberry-therapeutics-mycovia-pharmaceuticals-bausch-health-pfi\/","url":"https:\/\/ipsnews.net\/business\/2021\/05\/24\/onychomycosis-market-research-report-2030-industry-analysis-drugs-epidemiology-and-key-companies-by-delveinsight-moberg-pharma-blueberry-therapeutics-mycovia-pharmaceuticals-bausch-health-pfi\/","name":"Onychomycosis Market Research Report 2030: Industry Analysis, Drugs, Epidemiology and Key Companies by DelveInsight | Moberg Pharma, Blueberry Therapeutics, Mycovia Pharmaceuticals, Bausch Health, Pfizer and Others - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ipsnews.net\/business\/2021\/05\/24\/onychomycosis-market-research-report-2030-industry-analysis-drugs-epidemiology-and-key-companies-by-delveinsight-moberg-pharma-blueberry-therapeutics-mycovia-pharmaceuticals-bausch-health-pfi\/#primaryimage"},"image":{"@id":"https:\/\/ipsnews.net\/business\/2021\/05\/24\/onychomycosis-market-research-report-2030-industry-analysis-drugs-epidemiology-and-key-companies-by-delveinsight-moberg-pharma-blueberry-therapeutics-mycovia-pharmaceuticals-bausch-health-pfi\/#primaryimage"},"thumbnailUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-DelveInsight20Logo2028229.jpg","datePublished":"2021-05-24T10:00:00+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee"},"breadcrumb":{"@id":"https:\/\/ipsnews.net\/business\/2021\/05\/24\/onychomycosis-market-research-report-2030-industry-analysis-drugs-epidemiology-and-key-companies-by-delveinsight-moberg-pharma-blueberry-therapeutics-mycovia-pharmaceuticals-bausch-health-pfi\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ipsnews.net\/business\/2021\/05\/24\/onychomycosis-market-research-report-2030-industry-analysis-drugs-epidemiology-and-key-companies-by-delveinsight-moberg-pharma-blueberry-therapeutics-mycovia-pharmaceuticals-bausch-health-pfi\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/2021\/05\/24\/onychomycosis-market-research-report-2030-industry-analysis-drugs-epidemiology-and-key-companies-by-delveinsight-moberg-pharma-blueberry-therapeutics-mycovia-pharmaceuticals-bausch-health-pfi\/#primaryimage","url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-DelveInsight20Logo2028229.jpg","contentUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-DelveInsight20Logo2028229.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/ipsnews.net\/business\/2021\/05\/24\/onychomycosis-market-research-report-2030-industry-analysis-drugs-epidemiology-and-key-companies-by-delveinsight-moberg-pharma-blueberry-therapeutics-mycovia-pharmaceuticals-bausch-health-pfi\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"Onychomycosis Market Research Report 2030: Industry Analysis, Drugs, Epidemiology and Key Companies by DelveInsight | Moberg Pharma, Blueberry Therapeutics, Mycovia Pharmaceuticals, Bausch Health, Pfizer and Others"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee","name":"iCrowdNewswire","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","caption":"iCrowdNewswire"},"sameAs":["https:\/\/heymuse.com\/ips"],"url":"http:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/114774","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/291"}],"replies":[{"embeddable":true,"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=114774"}],"version-history":[{"count":1,"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/114774\/revisions"}],"predecessor-version":[{"id":114775,"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/114774\/revisions\/114775"}],"wp:attachment":[{"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=114774"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=114774"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=114774"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}